Michael Detke

2021

In 2021, Michael Detke earned a total compensation of $631.8K as Chief Medical Officer at Cortexyme, a 92% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$177,750
Salary$450,000
Other$4,000
Total$631,750

Detke received $450K in salary, accounting for 71% of the total pay in 2021.

Detke also received $177.8K in non-equity incentive plan and $4K in other compensation.

Rankings

In 2021, Michael Detke's compensation ranked 10,183rd out of 12,415 executives tracked by ExecPay. In other words, Detke earned more than 18.0% of executives.

ClassificationRankingPercentile
All
10,183
out of 12,415
18th
Division
Manufacturing
4,503
out of 5,508
18th
Major group
Chemicals And Allied Products
2,010
out of 2,378
16th
Industry group
Drugs
1,783
out of 2,099
15th
Industry
Biological Products, Except Diagnostic Substances
388
out of 449
14th

Pay ratio

Michael Detke's Pay$631,750
Median Employee's Pay$622,098
Pay Ratio

1

to 1

In 2021, the annual total compensation of Michael Detke was $631,750.

The annual total compensation of the median employee at Cortexyme was $622,098.

The ratio of Michael Detke's pay to the pay of median employee was therefore 1 to one.

Source: SEC filing on April 27, 2022.

Detke's colleagues

We found four more compensation records of executives who worked with Michael Detke at Cortexyme in 2021.

2021

Christopher Lowe

Cortexyme

Chief Executive Officer

2021

Casey Lynch

Cortexyme

Chief Executive Officer

2021

Caryn McDowell

Cortexyme

Secretary

2021

Leslie Holsinger

Cortexyme

Executive Vice President of Preclinical Development

News

You may also like